Detalhe da pesquisa
1.
Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.
Genes Chromosomes Cancer
; 55(4): 375-88, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26815134
2.
Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and Splenomegaly.
Mediators Inflamm
; 2016: 5860657, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27672242
3.
Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis.
Blood
; 120(4): 761-7, 2012 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-22692507
4.
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis.
Blood
; 117(25): 6793-800, 2011 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21447834
5.
t(5;12)(q31;p13)/ETV6::ACSL6 and t(6;9)(p23;q34)/DEK::NUP214 concurrence in acute myeloid leukemia: an unusual association of two rare abnormalities.
Cancer Genet
; 262-263: 35-39, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34979355
6.
Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party.
Blood
; 113(15): 3428-34, 2009 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-19211938
7.
Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP.
Blood
; 114(24): 4939-43, 2009 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19797518
8.
Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia.
Blood
; 114(24): 4933-8, 2009 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19822896
9.
FGFR1 and KAT6A rearrangements in patients with hematological malignancies and chromosome 8p11 abnormalities: biological and clinical features.
Am J Hematol
; 91(3): E14-6, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26667788
10.
Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure.
Haematologica
; 94(12): 1758-61, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19608673
11.
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up.
Haematologica
; 94(2): 205-12, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19144656
12.
Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
Haematologica
; 93(12): 1792-6, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18838477
13.
Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain.
Haematologica
; 92(3): 401-4, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17339191
14.
Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis.
Oncoimmunology
; 6(10): e1345402, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29123956
15.
Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.
Oncotarget
; 8(18): 29906-29913, 2017 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28404889
16.
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia.
J Clin Oncol
; 23(18): 4100-9, 2005 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15867198
17.
Crucial factors of the inflammatory microenvironment (IL-1ß/TNF-α/TIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study.
Oncotarget
; 7(28): 43974-43988, 2016 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27304059
18.
Acute promyelocytic leukemia with amplification of PML-RARalpha rearrangement: clinical implications.
Leuk Res
; 32(12): 1941-3, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18468683
19.
BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia.
PLoS One
; 8(12): e81425, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24339928
20.
Low-level Bcr-Abl mutations are very rare in chronic myeloid leukemia patients who are in major molecular response on first-line nilotinib.
Leuk Res
; 35(11): 1527-9, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21762985